{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37992689",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "101291",
      "10.1016/j.xcrm.2023.101291",
      "S2666-3791(23)00485-8"
    ],
    "Journal": {
      "ISSN": "2666-3791",
      "JournalIssue": {
        "Volume": "4",
        "Issue": "11",
        "PubDate": {
          "Year": "2023",
          "Month": "Nov",
          "Day": "21"
        }
      },
      "Title": "Cell reports. Medicine",
      "ISOAbbreviation": "Cell Rep Med"
    },
    "ArticleTitle": "Immune imprinting as a barrier to effective COVID-19 vaccines.",
    "Pagination": {
      "StartPage": "101291",
      "MedlinePgn": "101291"
    },
    "Abstract": {
      "AbstractText": [
        "Wang and colleagues show that immune imprinting impairs neutralizing antibody titers for bivalent mRNA vaccination against SARS-CoV-2 Omicron subvariants. Imprinting from three doses of monovalent vaccine can be alleviated by BA.5 or BQ-lineage breakthrough infection but not by a bivalent booster.<sup>1</sup>."
      ],
      "CopyrightInformation": "Copyright \u00a9 2023 The Author(s). Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA; Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Faraone",
        "ForeName": "Julia N",
        "Initials": "JN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA. Electronic address: liu.6244@osu.edu."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Shan-Lu",
        "Initials": "SL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cell Rep Med",
    "NlmUniqueID": "101766894",
    "ISSNLinking": "2666-3791"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Breakthrough Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA, Messenger"
    }
  ],
  "CoiStatement": "Declaration of interests The authors declare no competing interests."
}